RightFit Trial Directory

Crohn's Disease clinical trials in Orlando, FL

21 recruiting crohn's disease studies with a site in Orlando, FL.

All trials in Orlando, FL · All Crohn's Disease trials

RecruitingPhase 3NCT06819878

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Hoffmann-La Roche

Brooksville, FL · Clearwater, FL · Coral Gables, FL · +92 more sites

RecruitingPhase 2NCT06958536

A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease

Sponsor: Sanofi

Kissimmee, FL · Lighthouse PT, FL · Miami, FL · +17 more sites

RecruitingPhase 2NCT07697456

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Sponsor: AbbVie

Bradenton, FL · Kissimmee, FL · Largo, FL · +57 more sites

RecruitingPhase 4NCT06581328

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Sponsor: Takeda

Brooksville, FL · Clearwater, FL · Hialeah, FL · +98 more sites

RecruitingPhase 3NCT06430801

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Sponsor: Merck Sharp & Dohme LLC

Clearwater, FL · Fort Myers, FL · Inverness, FL · +84 more sites

RecruitingPhase 2NCT06226883

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

Kissimmee, FL · Miami, FL · Orlando, FL · +22 more sites

RecruitingPhase 3NCT06937099

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Sponsor: Eli Lilly and Company

Miami, FL · Orlando, FL · +32 more sites

RecruitingPhase 3NCT06819891

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Hoffmann-La Roche

Doral, FL · Lakeland, FL · Lehigh Acres, FL · +58 more sites

RecruitingPhase 2NCT06233461

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Takeda

Clearwater, FL · Lakeland, FL · Miami Lakes, FL · +27 more sites

RecruitingPhase 2NCT06548542

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Sponsor: AbbVie

Clermont, FL · Gainesville, FL · Inverness, FL · +61 more sites

RecruitingPhase 3NCT05995353

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Sponsor: AbbVie

Orlando, FL · +10 more sites

RecruitingPhase 3NCT07184931

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Sanofi

Clermont, FL · Gainesville, FL · Kissimmee, FL · +122 more sites

RecruitingPhase 3NCT07184944

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Sanofi

Kissimmee, FL · Miami, FL · +31 more sites

RecruitingPhase 4NCT06045754

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Sponsor: Takeda

Kissimmee, FL · Orlando, FL · Tampa, FL · +38 more sites

RecruitingNot applicableNCT05230173

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Sponsor: Mayo Clinic

Jacksonville, FL · Orlando, FL · +22 more sites

RecruitingPhase not listedNCT07237516

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Sponsor: University of North Carolina, Chapel Hill

Miami, FL · Orlando, FL · +9 more sites

RecruitingPhase 4NCT06997965

Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD

Sponsor: Alimentiv Inc.

Orlando, FL · +1 more sites

RecruitingPhase 3NCT06227910

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

Sponsor: Takeda

Naples, FL · Orlando, FL · Tampa, FL · +16 more sites

RecruitingPhase 2NCT06456593

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Sponsor: Abivax S.A.

Brandon, FL · Clearwater, FL · Lakeland, FL · +40 more sites

RecruitingPhase 2NCT07113522

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Sponsor: Mirador Therapeutics, Inc.

Miami, FL · +43 more sites

Not yet recruitingPhase 2NCT07677514

A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease

Sponsor: Jiangsu Carephar Pharmaceutical Co., Ltd.

Lighthouse PT, FL · Orlando, FL · +1 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.